Genesys Capital | Genesys University Seed Fund
◆ Fund Size
$400M
◆ Check Size
◆ Location
Canada
◆ Portfolio
7 companies
◆ Activity
Statusactively investing
◆ Links
◆ Share this fund
◆ Investment Thesis
Early-stage capital for university-affiliated life sciences startups to translate research into viable companies addressing critical health challenges.
◆ About Genesys Capital
Genesys Capital is one of Canada's leading venture capital firms, dedicated to investing in early-stage healthcare and biotechnology companies. With over 25 years of experience, the firm has a proven track record of identifying and nurturing innovative bioscience opportunities, transforming them into commercially successful enterprises.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Christine Thoburn | Office Manager | Office Manager | |
| Damian Lamb | Co-founder, Managing Director | Managing Director | |
| Jamie Stiff | Managing Director | Managing Director | |
| Jennifer Williams | Partner and Chief Financial Officer | Partner | |
| Kelly Holman | Co-founder, Managing Director | Managing Director | |
| Laurie Mak | Associate | Associate | |
| Lisa Low | Senior Vice President, Finance | Senior Vice President | |
| Sarah Farr | Principal | Principal |
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Genesys University Seed Fund invest in?
Genesys University Seed Fund invests in Biotech, Drug Discovery, Diagnostics, Medtech and Digital Health at the pre-seed and seed stages.
Which geographies does Genesys University Seed Fund focus on?
Genesys University Seed Fund focuses on Canada and Ontario, and is headquartered in Canada.
What is Genesys University Seed Fund's typical check size?
Genesys University Seed Fund typically writes checks of $9.3M to $105M.